S L Blomgren - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

S L Blomgren

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

The New England Journal of Medicine|April 6, 1995

FluoxetineS L Blomgren, G D Tollefson

The Journal of Clinical Psychiatry|January 1, 1997

Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertralineM E Thase, S L Blomgren, M A Birkett, et al.

Journal of Clinical Psychopharmacology|April 22, 1999

Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxietyW T Smith, P D Londborg, S L Blomgren, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

The New England Journal of Medicine|April 6, 1995

FluoxetineS L Blomgren, G D Tollefson

The Journal of Clinical Psychiatry|January 1, 1997

Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertralineM E Thase, S L Blomgren, M A Birkett, et al.

Journal of Clinical Psychopharmacology|April 22, 1999

Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxietyW T Smith, P D Londborg, S L Blomgren, et al.

Pageof 1